Onconetix, Inc. business relationships

Companies named in Onconetix, Inc.’s 10-K filed 2026-03-13, and public companies whose annual reports name Onconetix, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.2 / 10
AI naming: <1 / 100
Agent readiness: 20 / 100
AI adoption: 0 / 100

Named in Onconetix, Inc.’s annual report 8

LABCORP HOLDINGS INC. (LH)Licensor7.7
“we anticipate will be marketed in the U.S. as a lab developed test through our license agreement with LabCorp.” SEC filing
LABCORP HOLDINGS INC. (LH)Partner7.7
“an exclusive partnership with LabCorp in 2023 pursuant to which LabCorp has the exclusive right to develop and commercialize Proclarix,” SEC filing
Roche GroupSupplier7.7
“provided by a few mid-sized to large diagnostic companies (e.g., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers AG, DiaSorin” SEC filing
ABBOTT LABORATORIES (ABT)Supplier6.7
“provided by a few mid-sized to large diagnostic companies (e.g., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers AG, DiaSorin” SEC filing
Siemens Healthineers (SMMNY)Supplier6.6
“provided by a few mid-sized to large diagnostic companies (e.g., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers AG, DiaSorin” SEC filing
DiaSorin (DSRNY)Supplier4.7
“provided by a few mid-sized to large diagnostic companies (e.g., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers AG, DiaSorin” SEC filing
Immunovia ABLicensor4.6
“2025, the Company entered into a license agreement with Immunovia AB, under which it granted exclusive rights to certain intellectual” SEC filing
Horizon Health LimitedPartner3.6
“development partnership with New Horizon Health Limited, Grand Cayman, Cayman Islands.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.